Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols

Ben-David, R., Tillu, N., Alerasool, P., Bieber, C., Ranti, D., Tolani, S., Eisenhauer, J., Chung, R., Lavallée, E., Waingankar, N., Attalla, K., Wiklund, P., Mehrazin, R., Anderson, C. B., & Sfakianos, J. P. (2024). Induction and maintenance of sequential intravesical gemcitabine/docetaxel for intermediate and high-risk non-muscle invasive bladder cancer with different dosage protocols. World Journal of Urology, 42(1). https://doi.org/10.1007/s00345-024-04992-5

Authors:

Reuben Ben-David

Neeraja Tillu

Parissa Alerasool

Christine Bieber

Daniel Ranti

Serena Tolani

Justin Eisenhauer

Rainjade Chung

Etienne Lavallée

Nikhil Waingankar

Kyrollis Attalla